FDA user fee reauthorization advances without $1B fee increase

By Stewart Eisenhart, Emergo Group

The US Senate’s version of a bill reauthorizing Food and Drug Administration user fees over the next several years diverges markedly from President Trump’s budget proposal to increase user fees by $1 billion in 2018 alone.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post FDA user fee reauthorization advances without $1B fee increase appeared first on MassDevice.

from MassDevice http://ift.tt/2uhPE2e